MetLife Investment Management, LLC

Position in PBYI — Puma Biotechnology, Inc.

CIK 1529735 Whippany, NJ

Position in PBYI

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$101,230

-$44,021 QoQ

Shares Held

15,842

-35.1% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $359,688,098 across 207 Biotechnology names. PBYI ranks #180 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	70,804	$31,616,818
2	PRAX	Praxis Precision Medicines, Inc.	80,930	$26,074,836
3	AXSM	Axsome Therapeutics, Inc.	152,645	$25,800,057
4	HALO	Halozyme Therapeutics, Inc.	374,931	$24,231,790
5	REGN	Regeneron Pharmaceuticals, Inc.	23,567	$18,208,806
6	FTRE	Fortrea Holdings Inc.	1,805,184	$17,004,833
7	ADMA	Adma Biologics, Inc.	1,738,062	$15,659,938
8	VRDN	Viridian Therapeutics, Inc.\DE	708,527	$13,858,788

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$101,230	15,842	-35.1%	Shares	Defined	2026-05-14
2025-12-31	$145,251	24,412	+67.8%	Shares	Defined	2026-02-12
2025-09-30	$77,233	14,545	-46.4%	Shares	Defined	2025-11-13
2025-06-30	$93,151	27,158	+0.1%	Shares	Defined	2025-08-13
2025-03-31	$80,278	27,121	+147.2%	Shares	Defined	2025-05-14
2024-06-30	$35,771	10,973	+358.7%	Shares	Defined	2024-08-13
2021-03-31	$23,250	2,392	-82.7%	Shares	Defined	2023-03-23
2020-12-31	$141,495	13,791	0.0%	Shares	Defined	2023-03-23
2020-09-30	$139,151	13,791	0.0%	Shares	Defined	2023-03-23
2020-06-30	$143,840	13,791	0.0%	Shares	Defined	2023-03-23
2020-03-31	$116,396	13,791	—	Shares	Defined	2023-03-23
No filing history on record for this holder in this stock.